Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patients

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.6, 2012-04, pp. : 873-878

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fentanyl Buccal Tablet: In Breakthrough Pain in Opioid-Tolerant Patients with Cancer

By Blick Stephanie K.A. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2387-2393

Adis International

Access to resources Recommend Favorite

Treatment strategies for cancer patients with breakthrough pain

By Casuccio Alessandra Mercadante Sebastiano Fulfaro Fabio

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 947-953

Informa Healthcare

Access to resources Recommend Favorite

Fentanyl Buccal Tablet in Breakthrough Pain in Opioid-Tolerant Patients with Cancer: A Viewpoint by Donald R. Taylor

By Taylor Donald R.

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2394-2395

Adis International

Access to resources Recommend Favorite

Newer Generation Fentanyl Transmucosal Products for Breakthrough Pain in Opioid-Tolerant Cancer Patients

By Elsner Frank

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 605-618

Adis International

Access to resources Recommend Favorite

Management of Breakthrough Pain in Patients with Cancer

By William Leeroy

Drugs, Vol. 68, Iss. 7, 2008-01 ,pp. : 913-924

Adis International

Access to resources Recommend Favorite